Upregulation of intrinsic apoptotic pathway in NSAIDs mediated chemoprevention of experimental lung carcinogenesis

[1]  S. Sanyal,et al.  Chemopreventive effects of NSAIDs on cytokines and transcription factors during the early stages of colorectal cancer , 2011 .

[2]  S. Sanyal,et al.  Non steroidal anti-inflammatory drugs modulate the physicochemical properties of plasma membrane in experimental colorectal cancer: a fluorescence spectroscopic study , 2011, Molecular and Cellular Biochemistry.

[3]  A. Wróbel,et al.  Combinatory effects of PBDEs and 17β-estradiol on MCF-7 cell proliferation and apoptosis , 2011, Pharmacological reports : PR.

[4]  S. Sanyal,et al.  Chemopreventive Role of Preferential COX-2 Inhibitor Diclofenac in 9, 10- Dimethybenz(a)anthracene Induced Experimental Lung Carcinogenesis , 2010 .

[5]  S. Sanyal,et al.  Inflammatory Response of Lung Derived Cells in Rat Pups Following Intratracheal Surfactant Instillation , 2010 .

[6]  S. Sanyal,et al.  Induction of pulmonary carcinogenesis in Wistar rats by a single dose of 9, 10 dimethylbenz(a)anthracene (DMBA) and the chemopreventive role of diclofenac. , 2010, Experimental and molecular pathology.

[7]  S. Mandal,et al.  COX-2 as a target for cancer chemotherapy , 2010, Pharmacological reports : PR.

[8]  A. Hacimuftuoglu,et al.  Gastric anti-ulcerative and anti-inflammatory activity of metyrosine in rats , 2010, Pharmacological reports : PR.

[9]  J. Kaur,et al.  Oxidative Stress and Stress-signaling in Chemoprevention of Early Colon Cancer by Diclofenac , 2010 .

[10]  S. Sanyal,et al.  Chemopreventive action of diclofenac in dimethybenzanthracene induced lung cancer in female Wistar rat. , 2010, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[11]  F. Coceani,et al.  Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouse , 2008, British journal of pharmacology.

[12]  D. Adriaensen,et al.  Functional live cell imaging of the pulmonary neuroepithelial body microenvironment. , 2008, American journal of respiratory cell and molecular biology.

[13]  S. Sanyal,et al.  Pulmonary Carcinogenesis in Mice with a Single Intratracheal Instillation of 9, 10-Dimethyl Benz[a]anthracene , 2008 .

[14]  D. Sheppard,et al.  Retraction. Induction of a homeostatic circuit in lung tissue by microbial compounds. , 2006, Immunity.

[15]  Randall Harris,et al.  Reduced Risk of Human Lung Cancer by Selective Cyclooxygenase 2 (Cox-2) Blockade: Results of a Case Control Study , 2007, International journal of biological sciences.

[16]  D. Sheppard,et al.  Induction of a homeostatic circuit in lung tissue by microbial compounds. , 2008, Immunity.

[17]  K. Kinnally,et al.  Is MAC the knife that cuts cytochrome c from mitochondria during apoptosis? , 2006, Cell Death and Differentiation.

[18]  John C Reed,et al.  Drug Insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms , 2006, Nature Clinical Practice Oncology.

[19]  S. Dubinett,et al.  The potential and rationale for COX-2 inhibitors in lung cancer. , 2006, Anti-cancer agents in medicinal chemistry.

[20]  Bart N Lambrecht,et al.  Alveolar macrophage in the driver's seat. , 2006, Immunity.

[21]  C. Rhee,et al.  Sulindac-derived reactive oxygen species induce apoptosis of human multiple myeloma cells via p38 mitogen activated protein kinase-induced mitochondrial dysfunction , 2006, Apoptosis.

[22]  S. Orrenius,et al.  Apoptosis: a basic biological phenomenon with wide‐ranging implications in human disease , 2005, Journal of internal medicine.

[23]  S. Fesik.  Promoting apoptosis as a strategy for cancer drug discovery , 2005, Nature Reviews Cancer.

[24]  K. Schulze-Osthoff,et al.  New Approaches and Therapeutics Targeting Apoptosis in Disease , 2005, Pharmacological Reviews.

[25]  S. Lowe,et al.  Intrinsic tumour suppression , 2004, Nature.

[26]  M. Singh,et al.  Evaluation of An Aerosolized Selective COX-2 Inhibitor as a Potentiator of Doxorubicin in a Non-Small-Cell Lung Cancer Cell Line , 2003, Pharmaceutical Research.

[27]  G. Kroemer,et al.  The cell biology of apoptosis: Evidence for the implication of mitochondria , 1996, Apoptosis.

[28]  Yingjin Yuan,et al.  Differentiation of apoptotic and necrotic cells in suspension cultures of Taxus cuspidata by the combined use of fluorescent dying and histochemical staining methods , 2004, Biotechnology Letters.

[29]  C. Tohyama,et al.  Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice. , 2003, Carcinogenesis.

[30]  W. Schmiegel,et al.  Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells. , 2003, Carcinogenesis.

[31]  K. Subbaramaiah,et al.  Cyclooxygenase 2: a molecular target for cancer prevention and treatment. , 2003, Trends in pharmacological sciences.

[32]  Chi Han,et al.  Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. , 2002, Carcinogenesis.

[33]  Randall Harris,et al.  Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. , 2002, Oncology reports.

[34]  R Gordon,et al.  Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. , 2001, The Journal of pharmacology and experimental therapeutics.

[35]  S. Salvioli,et al.  Flow Cytometric Analysis of Mitochondrial Membrane Potential Using JC‐1 , 2000, Current protocols in cytometry.

[36]  J. Góra‐Tybor,et al.  [Apoptosis--programmed cell death]. , 1994, Postepy higieny i medycyny doswiadczalnej.

[37]  R Williams,et al.  A means to an end , 2006, British Dental Journal.

[38]  A. Pearse.  Histochemistry: Theoretical and Applied , 1953 .